G protein β3 subunit C825T polymorphism modifies the presentation of temporal lobe epilepsy

Acta Neurologica Scandinavica

Volumn 117, Issue SUPPL. 188, 2008, Pages 62-66

  Osberg, S ^a   Melien, Ø ^a   Tauboll E ^a,b   Gjerstad, L ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

C825T polymorphism; G protein; Temporal lobe epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA3 SUBUNIT; G PROTEIN BETA3 SUBUNIT; G-PROTEIN BETA3 SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; DNA EXTRACTION; DNA FINGERPRINTING; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PREVALENCE; SCORING SYSTEM; TEMPORAL LOBE EPILEPSY; WAIST CIRCUMFERENCE; WEIGHT CHANGE; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; HOSPITALIZATION; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; CASE-CONTROL STUDIES; EPILEPSY, TEMPORAL LOBE; FEMALE; GENOTYPE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 42649092873     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01034.x     Document Type: Article

References (27)

1. Engel J Jr., Williamson PD, Wieser H-G. Mesial temporal lobe epilepsy. In:Engel J Jr., Pedley TA, eds. Epilepsy: a comprehensive textbook. New York:Lippincott, Raven, 1998 2417 23.
2. Majores M, Eils J, Wiestler O, Becker AJ. Molecular profiling of temporal lobe epilepsy: comparison of data from human tissue samples and animal models. Epilepsy Res 2004 60:173 8.
3. Notenboom RG, Hampson DR, Jansen GH et al. Up-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients. Brain 2006 129 (Part 1 96 107.
4. Csaba Z, Pirker S, Lelouvier B et al. Somatostatin receptor type 2 undergoes plastic changes in the human epileptic dentate gyrus. J Neuropathol Exp Neurol 2005 64:956 69.
5. Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G. Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 2001 21:5804 12.
6. Loup F, Wieser HG, Yonekawa Y, Aguzzi A, Fritschy JM. Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 2000 20:5401 19.
7. Marsh DJ, Baraban SC, Hollopeter G, Palmiter RD. Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 1999 96:13518 23.
8. Magloczky Z, Freund TF. Impaired and repaired inhibitory circuits in the epileptic human hippocampus. Trends Neurosci 2005 28:334 40.
9. Williams SF, Colling SB, Whittinton MA, Jeffreys JG. Epileptic focus induced by intrahippocampal cholera toxin in rat: time course and properties in vivo and in vitro. Epilepsy Res 1993 16:137 46.
10. Mazarati A, Lu X. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors. Neuropeptides 2005 39:277 80.
11. B receptor binding in thalamus of a genetically prone rat (GAERS). Neuropharmacol 1999 38:1691 7.
12. Iwasa H, Kikuchi S, Miyagishima H, Mine S, Koseki K, Hasegawa S. Altered expression levels of G protein subclass mRNAs in various seizure stages of the kindling model. Brain Res 1999 818:570 4.
13. 3 are lean and have seizures. Mol Cell Biol 2004 24:7758 68.
14. Siffert W, Rosskopf D, Siffert G et al. Association of a human G-protein β3 subunit variant with hypertension. Nat Genet 1998 18:45 8.
15. Siffert W. G protein β3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy. Nephrol Dial Transplant 2000 15:1298 306.
16. Lee H-J, Cha J-H, Ham B-J et al. Association between a G-protein β3 subunit polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J 2004 4:29 33.
17. Fernández-Real JM, Peñarroja G, Richart C et al. G Protein β3 gene variant, vascular function and insulin sensivity in Type 2 diabetes. Hypertension 2003 41:124 9.
18. Hauner H, Meier M, Jöckel K-H, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein β3 subunit gene (GNβ3) C825T polymorphism. Pharmacogenetics 2003 13:453 9.
19. Sarrazin C, Berg T, Weich V et al. GNβ3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection. J Hepatol 2005 43:388 93.
20. Seretti A, Lorenzi C, Cusin C et al. SSRIs antidepressant activity is influenced by Gβ3 variants. Eur Neuropsychopharmacol 2003 13:117 22.
21. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein β3 subunit and antihypertensive response to at thiazide diuretic. Hypertension 2001 37 (Part 2 739 43.
22. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989 30:389 99.
23. Opdal SH, Melien Ø, Rootwelt H, Vege Å, Arnestad M, Rognum TO. The G-protein beta3 subunit 825C allele is associated with sudden infant death due to infection. Acta Paediatr 2006 95:1129 32.
24. Siffert W, Forster P, Jöckel K-H et al. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and black African individuals. J Am Soc Nephrol 1999 10:1921 30.
25. Pfaffinger PJ, Martin JM, Hunter DD, Nathanson NM, Hille B. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature 1985 317:536 40.
26. Bernard C, Anderson A, Becker A, Poolos NP, Beck H, Johnston D. Acquired dendritic channelopathy in temporal lobe epilepsy. Science 2004 305:532 5.
27. Melien Ø. Heterotrimeric G proteins and disease. Methods Mol Biol 2007 361:119 44.